🇺🇸 FDA
Pipeline program

Durability of protection after single immunisation with genetically attenuated Plasmodium falciparum ∆mei2 (GA2) sporozoites – a follow-up, controlled human malaria rechallenge study

Phase 2 other active

Quick answer

Durability of protection after single immunisation with genetically attenuated Plasmodium falciparum ∆mei2 (GA2) sporozoites – a follow-up, controlled human malaria rechallenge study for Falciparum malaria is a Phase 2 program (other) at Disc Medicine with 1 ClinicalTrials.gov record(s).

Program details

Company
Disc Medicine
Indication
Falciparum malaria
Phase
Phase 2
Modality
other
Status
active

Clinical trials